Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
26
MTNB Quote, Financials, Valuation and Earnings
Last price:
$0.99
Seasonality move
:
12.45%
Day range:
$0.96 - $1.02
52-week range:
$0.47 - $9.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.18x
P/B ratio:
0.81x
Volume:
37.3K
Avg. volume:
380.5K
1-year change:
-89.28%
Market cap:
$5.1M
Revenue:
$1.1M
EPS (TTM):
-$3.86
Earnings Data
Next earnings date for MTNB
Aug 14
2025
Most recent earnings per share
-$0.33
Missed by $0.33
(May 15/2025)
Consensus Estimate
--
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MTNB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/14/2025 | Q2 | -- | -- | -- | -- | -- |
| 05/15/2025 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/27/2025 | Q4 | -- | -- | -$1.68 | -$0.78 | -$0.90 |
| 11/13/2024 | Q3 | -- | -- | -$0.85 | -$1.06 | $0.21 |
| 08/14/2024 | Q2 | -- | -- | -$1.00 | -$1.00 | -- |
| 05/09/2024 | Q1 | -- | -- | -$1.34 | -$1.50 | $0.16 |
| 03/27/2024 | Q4 | -- | -- | -$1.22 | -$1.50 | $0.28 |
| 11/08/2023 | Q3 | -- | -- | -$1.39 | -$1.50 | $0.11 |
| 08/09/2023 | Q2 | -- | -- | -$1.50 | -$1.50 | -- |
| 05/10/2023 | Q1 | -- | $1.1M | -$1.50 | -- | -- |
| 03/15/2023 | Q4 | -- | $1.1M | -$1.00 | -- | -- |
| 11/02/2022 | Q3 | -- | $1.1M | -$1.50 | -- | -- |
| 08/11/2022 | Q2 | -- | $1.1M | -$1.50 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/08/2022 | Q4 | -- | -$330 | -$1.50 | -- | -- |
| 11/08/2021 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$1.00 | -- | -- |
| 05/10/2021 | Q1 | -- | $33.3K | -$1.50 | -- | -- |
| 03/29/2021 | Q4 | -- | $62.5K | -$1.50 | -- | -- |
| 11/06/2020 | Q3 | -- | $95.8K | -$1.50 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$1.50 | -- | -- |
| 05/11/2020 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/09/2020 | Q4 | -- | -- | -$2.00 | -- | -- |
| 11/13/2019 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/13/2019 | Q2 | -- | $89.8K | -$1.50 | -- | -- |
| 04/02/2019 | Q1 | -- | -- | -$2.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$1.50 | -- | -- |
| 11/12/2018 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/10/2018 | Q2 | -- | $89.8K | -$2.00 | -- | -- |
| 05/10/2018 | Q1 | -- | $29.9K | -$2.50 | -- | -- |
| 03/19/2018 | Q4 | -- | $44.9K | -$2.00 | -- | -- |
| 11/15/2017 | Q3 | -- | $44.9K | -$2.00 | -- | -- |
| 08/08/2017 | Q2 | -- | $44.9K | -$2.00 | -- | -- |
| 03/31/2017 | Q1 | -- | $15K | -$12.50 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$1.50 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$5.50 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$1.50 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$2.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2.00 | -- | -- |
| 09/30/2015 | Q3 | -- | $59.9K | -$2.00 | -- | -- |
Matinas BioPharma Holdings Earnings Questions
-
How Much did Matinas BioPharma Holdings Generate in Revenue Last Quarter?
Matinas BioPharma Holdings reported -- worth of top line sales in its most recent quarter.
-
Did Matinas BioPharma Holdings Beat Earnings Last Quarter?
Matinas BioPharma Holdings announced earnings per share of -$0.33 which represents a miss of analyst forecast a -- per share.
-
Is Matinas BioPharma Holdings Profitable?
Matinas BioPharma Holdings reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Matinas BioPharma Holdings EPS Next Year?
Matinas BioPharma Holdings's earnings are forecast to decrease from -$4.98 per share to -$4.06 per share next year representing a decrease of -69.88%.
-
When is Matinas BioPharma Holdings's Earnings Date?
Matinas BioPharma Holdings's next earnings date is August 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
